Literature DB >> 9609404

Fixed-dose combination therapy: panacea or poison?

R B Rao, L R Goldfrank.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9609404     DOI: 10.1007/s001340050569

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

Review 1.  Pharmacological basis for combination therapy of hypertension.

Authors:  C T Dolley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 2.  New drugs for hypertension: should data precede conclusions?

Authors:  M G Myers
Journal:  CMAJ       Date:  1990-08-15       Impact factor: 8.262

Review 3.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

4.  Plasma electrolytes in elderly patients taking fixed combination diuretics.

Authors:  A J Bayer; R Farag; S Browne; M S Pathy
Journal:  Postgrad Med J       Date:  1986-03       Impact factor: 2.401

5.  What's in a brand name?

Authors:  J K Aronson
Journal:  BMJ       Date:  1994-04-30

6.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

Review 7.  The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy.

Authors:  M Epstein
Journal:  Ren Fail       Date:  1996-11       Impact factor: 2.606

8.  Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy.

Authors:  T F Chiu; M J Bullard; J C Chen; S J Liaw; C J Ng
Journal:  Ann Emerg Med       Date:  1997-11       Impact factor: 5.721

9.  A "lipo-protective" effect of a fixed combination of captopril and hydrochlorothiazide in antihypertensive therapy.

Authors:  K Ratheiser; J Dusleag; K Seitl; G Titscher; W Klein
Journal:  Clin Cardiol       Date:  1992-09       Impact factor: 2.882

Review 10.  Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?

Authors:  G L Bakris; B Williams
Journal:  J Hypertens Suppl       Date:  1995-08
View more
  1 in total

Review 1.  Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

Authors:  William H Frishman; Linda S Henderson; Mary Ann Lukas
Journal:  Vasc Health Risk Manag       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.